Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-07-29
1998-10-13
Owens, Amelia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514100, 5142328, 514255, 514320, 514337, 514422, 549218, 549219, 549511, 548525, 546196, 5462817, 544147, 544359, A61K 31335, A61K 3144, A61K 31445, A61K 31495
Patent
active
058212639
ABSTRACT:
This invention provides a novel series of taxane derivatives which are characterized by the C3' nitrogen bearing one or two sulfur substituents. The new derivatives are antitumor agents useful in the treatment of such cancers as ovarian, breast, lung, gastric, colon, head and neck, melanoma and leukemia.
REFERENCES:
patent: 5453520 (1995-09-01), Bombardelli et al.
patent: 5496846 (1996-03-01), Wilson et al.
patent: 5714512 (1998-02-01), Bastart et al.
Scola Paul M.
Vyas Dolatrai M.
Bristol--Myers Squibb Company
Morse David M.
Owens Amelia
LandOfFree
Sulfenamide taxane derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfenamide taxane derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfenamide taxane derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-313554